Zhengzhou Haidibanglin Pharmaceutical

Zhengzhou Haidibanglin Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and manufacturing of antiviral and hepatoprotective medications. The company is best known for its production of generic and specialized small molecule drugs targeting chronic hepatitis B and other liver-related conditions. Its portfolio includes widely used antiviral agents such as adefovir dipivoxil and entecavir, which are critical for managing long-term viral suppression in patients. Operating out of Zhengzhou, the company maintains GMP-certified manufacturing facilities to supply the domestic Chinese market. Haidibanglin focuses on providing affordable, high-quality therapeutic options for prevalent infectious diseases and chronic metabolic disorders.